LJAC
TAK icon

L.J. Altfest & Co’s Takeda Pharmaceutical TAK Stock Holding History

L.J. Altfest & Co’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,832
Closed -$270K – 295
2020
Q4 		$270K Buy
+14,832
New +$260K 0.07% 214

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

L.J. Altfest & Co's TAK Position: Q1 2021 in Review

L.J. Altfest & Co sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 14,832 shares — an estimated $270K sold.

L.J. Altfest & Co first reported a position in TAK in Q4 2020 and held it in 1 quarter. The position peaked at $270K in Q4 2020. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

  • L.J. Altfest & Co reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • L.J. Altfest & Co sold 14,832 Takeda Pharmaceutical shares in Q1 2021, an estimated $270K.
  • L.J. Altfest & Co first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 1 quarter.
  • L.J. Altfest & Co's Takeda Pharmaceutical position peaked at $270K in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on L.J. Altfest & Co's 13F filing for Q1 2021, filed 7 May 2021.